Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Spdr S&p 500 Etf Tr option, RVMD, AMZN, MSFT, AON, and represent 30.65% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Spdr S&p 500 Etf Tr option (+$1.5B), Invesco Exchange Traded Fd T put (+$691M), AVGO (+$275M), ROIV (+$267M), KKR (+$246M), MA (+$131M), TMO (+$121M), SNPS (+$85M), PCVX (+$73M), DNTH (+$70M).
- Started 51 new stock positions in NVO, GDS, ALMS, VIR, JNJ, FORM, Apellis Pharmaceuticals, VRT, NKTR, TENB.
- Reduced shares in these 10 stocks: , RSP (-$690M), , HYG (-$645M), CYBR (-$470M), LLY (-$403M), , NDAQ (-$290M), Avidity Biosciences Ord (-$233M), NYT (-$228M).
- Sold out of its positions in ALNY, ACLX, Ascendis Pharma A S, Avidity Biosciences Ord, CBRE, Ceridian Hcm Hldg, CDTX, DOCS, EXACT Sciences Corporation, ETH.
- Farallon Capital Management was a net seller of stock by $-3.7B.
- Farallon Capital Management has $18B in assets under management (AUM), dropping by -20.53%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 172 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| State Str Spdr S&p 500 Etf T Tr Unit Put Option | 8.5 | $1.5B | NEW | 2.3M | 650.34 |
|
| Revolution Medicines (RVMD) | 7.5 | $1.3B | -6% | 14M | 97.25 |
|
| Amazon (AMZN) | 5.0 | $879M | -6% | 4.2M | 208.27 |
|
| Microsoft Corporation (MSFT) | 4.9 | $868M | +5% | 2.3M | 370.17 |
|
| Aon Shs Cl A (AON) | 4.6 | $811M | -5% | 2.5M | 322.78 |
|
| Bridgebio Pharma (BBIO) | 4.0 | $696M | +4% | 9.4M | 74.26 |
|
| Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option | 3.9 | $691M | NEW | 3.6M | 191.92 |
|
| Protagonist Therapeutics (PTGX) | 3.8 | $669M | +3% | 6.3M | 105.40 |
|
| Natera (NTRA) | 3.7 | $641M | -18% | 3.2M | 199.99 |
|
| Exelixis (EXEL) | 3.2 | $562M | -16% | 13M | 42.89 |
|
| Broadcom (AVGO) | 3.1 | $551M | +99% | 1.8M | 309.51 |
|
| UnitedHealth (UNH) | 2.8 | $493M | +13% | 1.8M | 270.59 |
|
| Synopsys (SNPS) | 2.7 | $481M | +21% | 1.2M | 396.48 |
|
| Boston Scientific Corporation (BSX) | 2.7 | $469M | 7.5M | 62.75 |
|
|
| Thermo Fisher Scientific (TMO) | 2.5 | $433M | +38% | 882k | 491.53 |
|
| Kkr & Co (KKR) | 2.5 | $432M | +131% | 4.7M | 92.50 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.4 | $424M | +2% | 5.6M | 75.85 |
|
| Wabtec Corporation (WAB) | 2.3 | $402M | -34% | 1.6M | 249.91 |
|
| Charles Schwab Corporation (SCHW) | 2.1 | $372M | +18% | 4.0M | 93.98 |
|
| Liquidia Corporation Com New (LQDA) | 1.9 | $327M | 8.7M | 37.74 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $303M | +20% | 8.3M | 36.32 |
|
| Alphabet Cap Stk Cl C (GOOG) | 1.6 | $286M | +26% | 996k | 286.86 |
|
| Roivant Sciences SHS (ROIV) | 1.5 | $268M | +26048% | 9.7M | 27.70 |
|
| Visa Com Cl A (V) | 1.4 | $254M | +20% | 841k | 302.24 |
|
| Aramark Hldgs (ARMK) | 1.4 | $249M | -34% | 6.1M | 40.54 |
|
| Beam Therapeutics (BEAM) | 1.4 | $242M | 10M | 23.83 |
|
|
| Walt Disney Company (DIS) | 1.3 | $232M | -41% | 2.4M | 96.38 |
|
| Mastercard Incorporated Cl A (MA) | 1.2 | $217M | +151% | 435k | 499.66 |
|
| McKesson Corporation (MCK) | 1.2 | $203M | -21% | 234k | 865.36 |
|
| Agios Pharmaceuticals (AGIO) | 1.1 | $192M | +10% | 5.7M | 33.83 |
|
| Centessa Pharmaceuticals Sponsored Ads | 1.1 | $191M | -10% | 4.8M | 39.72 |
|
| Tango Therapeutics (TNGX) | 1.1 | $190M | -30% | 9.1M | 20.92 |
|
| Grail (GRAL) | 1.0 | $168M | +38% | 3.3M | 51.68 |
|
| Tyra Biosciences (TYRA) | 0.8 | $137M | +73% | 3.6M | 38.30 |
|
| Tenet Healthcare Corp Com New (THC) | 0.5 | $85M | +21% | 452k | 188.71 |
|
| Cardinal Health (CAH) | 0.4 | $78M | -36% | 368k | 211.31 |
|
| Vaxcyte (PCVX) | 0.4 | $73M | +25120% | 1.3M | 58.11 |
|
| Dianthus Therapeutics (DNTH) | 0.4 | $70M | NEW | 836k | 83.92 |
|
| Brightspring Health Svcs (BTSG) | 0.4 | $69M | +7250% | 1.6M | 42.61 |
|
| Twist Bioscience Corp (TWST) | 0.4 | $68M | +18562% | 1.4M | 47.52 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.3 | $49M | +40% | 444k | 111.42 |
|
| Cg Oncology (CGON) | 0.3 | $46M | +8325% | 674k | 67.68 |
|
| Astrazeneca Ord (AZN) | 0.3 | $45M | NEW | 227k | 197.22 |
|
| Vnet Group Note 2.000%10/0 (Principal) | 0.3 | $45M | NEW | 45M | 0.99 |
|
| Merck & Co (MRK) | 0.2 | $43M | NEW | 361k | 120.29 |
|
| Acadia Healthcare (ACHC) | 0.2 | $41M | NEW | 1.7M | 23.39 |
|
| Welltower Inc Com reit (WELL) | 0.2 | $40M | -41% | 200k | 197.71 |
|
| Immunovant (IMVT) | 0.2 | $38M | +12783% | 1.5M | 24.84 |
|
| Enanta Pharmaceuticals (ENTA) | 0.2 | $36M | +3% | 2.9M | 12.63 |
|
| Johnson & Johnson (JNJ) | 0.2 | $36M | NEW | 148k | 244.44 |
|
| Beta Bionics (BBNX) | 0.2 | $36M | -16% | 3.6M | 10.02 |
|
| Assembly Biosciences Com New (ASMB) | 0.2 | $34M | 1.2M | 27.75 |
|
|
| Joyy Ads Repstg Com A (JOYY) | 0.2 | $34M | 578k | 58.39 |
|
|
| Strategy Note 12/0 (Principal) | 0.2 | $33M | NEW | 40M | 0.83 |
|
| Netease Sponsored Ads (NTES) | 0.2 | $33M | NEW | 291k | 111.94 |
|
| Novo-nordisk A S Adr (NVO) | 0.2 | $29M | NEW | 782k | 36.75 |
|
| Bitwise 10 Crypto Index Etf Unit Beneficial (BITW) | 0.2 | $27M | -82% | 603k | 44.61 |
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.1 | $25M | 2.3M | 10.97 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 0.1 | $24M | NEW | 493k | 47.97 |
|
| Minerva Neurosciences Com New (NERV) | 0.1 | $14M | 2.4M | 6.03 |
|
|
| CECO Environmental (CECO) | 0.1 | $14M | NEW | 234k | 59.58 |
|
| Avalo Therapeutics Com New (AVTX) | 0.1 | $14M | NEW | 916k | 14.93 |
|
| Cg Oncology Call Option | 0.1 | $14M | NEW | 200k | 67.68 |
|
| GDS HLDGS Sponsored Ads (GDS) | 0.1 | $12M | NEW | 292k | 40.29 |
|
| Maze Therapeatics (MAZE) | 0.1 | $11M | NEW | 373k | 29.85 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.1 | $11M | +785% | 354k | 30.12 |
|
| FormFactor (FORM) | 0.0 | $5.5M | NEW | 57k | 96.99 |
|
| MasTec (MTZ) | 0.0 | $5.5M | NEW | 17k | 321.74 |
|
| Entegris (ENTG) | 0.0 | $5.3M | NEW | 46k | 117.24 |
|
| Citigroup Com New (C) | 0.0 | $5.3M | NEW | 47k | 113.41 |
|
| Vnet Group Sponsored Ads A (VNET) | 0.0 | $5.2M | -90% | 623k | 8.39 |
|
| Hyatt Hotels Corp Com Cl A (H) | 0.0 | $5.2M | NEW | 36k | 143.79 |
|
| Western Alliance Bancorporation (WAL) | 0.0 | $5.2M | NEW | 73k | 70.85 |
|
| Timken Company (TKR) | 0.0 | $5.1M | NEW | 51k | 100.57 |
|
| Flextronics Intl Ord (FLEX) | 0.0 | $5.1M | NEW | 78k | 65.46 |
|
| S&p Global (SPGI) | 0.0 | $5.1M | NEW | 12k | 425.34 |
|
| Littelfuse (LFUS) | 0.0 | $5.1M | NEW | 15k | 339.35 |
|
| Piper Sandler Companies Com New (PIPR) | 0.0 | $5.1M | NEW | 66k | 76.55 |
|
| Aar (AIR) | 0.0 | $5.0M | NEW | 46k | 109.46 |
|
| Rio Tinto Sponsored Adr (RIO) | 0.0 | $5.0M | NEW | 54k | 93.29 |
|
| Garrett Motion (GTX) | 0.0 | $5.0M | NEW | 275k | 18.17 |
|
| Rollins (ROL) | 0.0 | $5.0M | NEW | 93k | 53.41 |
|
| Affirm Hldgs Com Cl A (AFRM) | 0.0 | $4.9M | NEW | 108k | 45.82 |
|
| Inter & Co Class A Com (INTR) | 0.0 | $4.9M | NEW | 615k | 7.96 |
|
| Cummins (CMI) | 0.0 | $4.8M | NEW | 9.0k | 538.02 |
|
| Fiserv (FISV) | 0.0 | $4.8M | NEW | 86k | 55.80 |
|
| Vertiv Holdings Com Cl A (VRT) | 0.0 | $4.8M | NEW | 19k | 250.58 |
|
| Amkor Technology (AMKR) | 0.0 | $4.7M | -77% | 104k | 45.03 |
|
| Atrium Therapeutics (RNA) | 0.0 | $4.7M | NEW | 349k | 13.37 |
|
| Globalfoundries Ordinary Shares (GFS) | 0.0 | $4.7M | NEW | 105k | 44.48 |
|
| Molina Healthcare (MOH) | 0.0 | $4.7M | NEW | 35k | 133.30 |
|
| Ocuphire Pharma (IRD) | 0.0 | $4.6M | NEW | 1.0M | 4.55 |
|
| Tenable Hldgs (TENB) | 0.0 | $4.5M | NEW | 265k | 16.91 |
|
| Prime Medicine (PRME) | 0.0 | $4.3M | 1.2M | 3.48 |
|
|
| Servicenow (NOW) | 0.0 | $4.3M | NEW | 41k | 104.55 |
|
| Summit Midstream Corporation (SMC) | 0.0 | $1.8M | 58k | 30.24 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $1.7M | 3.3k | 523.47 |
|
|
| Capricor Therapeutics Com New (CAPR) | 0.0 | $1.2M | 41k | 30.40 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $991k | 16k | 62.70 |
|
|
| Aleanna *w Exp 12/13/202 (ANNAW) | 0.0 | $802k | 990k | 0.81 |
|
|
| Guardant Health (GH) | 0.0 | $739k | -92% | 8.0k | 92.37 |
|
| Alkermes SHS (ALKS) | 0.0 | $736k | 21k | 35.36 |
|
|
| Alvotech Ordinary Shares (ALVO) | 0.0 | $685k | 200k | 3.43 |
|
|
| Axsome Therapeutics (AXSM) | 0.0 | $676k | 4.0k | 169.02 |
|
|
| Cogent Biosciences (COGT) | 0.0 | $654k | 17k | 38.49 |
|
|
| Aleanna Com Cl A (ANNA) | 0.0 | $650k | 78k | 8.29 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $613k | 26k | 23.56 |
|
|
| Celcuity (CELC) | 0.0 | $457k | 4.0k | 114.14 |
|
|
| Livanova SHS (LIVN) | 0.0 | $381k | 6.0k | 63.56 |
|
|
| Terns Pharmaceuticals (TERN) | 0.0 | $369k | -98% | 7.0k | 52.72 |
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $360k | 4.8k | 75.09 |
|
|
| Travere Therapeutics (TVTX) | 0.0 | $357k | 12k | 29.71 |
|
|
| Globus Med Cl A (GMED) | 0.0 | $345k | 4.0k | 86.16 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $344k | 7.0k | 49.16 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 0.0 | $327k | 1.1k | 296.97 |
|
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $321k | -92% | 5.0k | 64.22 |
|
| AmerisourceBergen (COR) | 0.0 | $314k | 1.0k | 314.14 |
|
|
| Nuvalent Inc-a (NUVL) | 0.0 | $307k | 3.0k | 102.45 |
|
|
| Progyny (PGNY) | 0.0 | $306k | 18k | 16.98 |
|
|
| Stoke Therapeutics (STOK) | 0.0 | $293k | 9.0k | 32.56 |
|
|
| Erasca (ERAS) | 0.0 | $291k | NEW | 18k | 16.18 |
|
| Encompass Health Corp (EHC) | 0.0 | $290k | -98% | 3.0k | 96.73 |
|
| Nektar Therapeutics Com New (NKTR) | 0.0 | $288k | NEW | 4.0k | 71.95 |
|
| Glaukos (GKOS) | 0.0 | $280k | 2.6k | 107.66 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $277k | 3.0k | 92.38 |
|
|
| Sabra Health Care REIT (SBRA) | 0.0 | $269k | 14k | 19.23 |
|
|
| Krystal Biotech (KRYS) | 0.0 | $258k | -50% | 1.0k | 258.32 |
|
| Omeros Corporation (OMER) | 0.0 | $243k | 23k | 10.56 |
|
|
| Alumis (ALMS) | 0.0 | $242k | NEW | 11k | 22.03 |
|
| Apellis Pharmaceuticals | 0.0 | $241k | NEW | 6.0k | 40.23 |
|
| Healthequity (HQY) | 0.0 | $234k | -44% | 2.8k | 83.57 |
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $234k | 10k | 23.36 |
|
|
| Amicus Therapeutics (FOLD) | 0.0 | $231k | 16k | 14.46 |
|
|
| Uniqure Nv SHS (QURE) | 0.0 | $229k | 14k | 16.35 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $229k | 24k | 9.52 |
|
|
| Veracyte (VCYT) | 0.0 | $226k | 7.0k | 32.21 |
|
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $225k | 28k | 8.02 |
|
|
| Abivax Sa Sponsored Ads (ABVX) | 0.0 | $223k | -99% | 2.0k | 111.35 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.0 | $214k | 3.0k | 71.18 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $209k | 120k | 1.74 |
|
|
| Hims & Hers Health Com Cl A (HIMS) | 0.0 | $208k | -99% | 10k | 20.76 |
|
| Belite Bio Sponsored Ads (BLTE) | 0.0 | $207k | NEW | 1.3k | 159.44 |
|
| Merit Medical Systems (MMSI) | 0.0 | $207k | 3.0k | 68.93 |
|
|
| Supernus Pharmaceuticals (SUPN) | 0.0 | $207k | NEW | 4.0k | 51.69 |
|
| Healthcare Rlty Tr Cl A Com (HR) | 0.0 | $204k | 12k | 16.99 |
|
|
| Urogen Pharma (URGN) | 0.0 | $198k | 11k | 17.98 |
|
|
| Vir Biotechnology (VIR) | 0.0 | $197k | NEW | 22k | 8.96 |
|
| Precigen (PGEN) | 0.0 | $194k | 50k | 3.87 |
|
|
| Schrodinger (SDGR) | 0.0 | $193k | -76% | 17k | 11.36 |
|
| Dyne Therapeutics (DYN) | 0.0 | $181k | 10k | 18.13 |
|
|
| Novavax Com New (NVAX) | 0.0 | $179k | -88% | 22k | 8.14 |
|
| Pacific Biosciences of California (PACB) | 0.0 | $178k | 135k | 1.32 |
|
|
| Sellas Life Sciences Group I Com New (SLS) | 0.0 | $169k | NEW | 40k | 4.23 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.0 | $153k | 11k | 13.88 |
|
|
| Ocular Therapeutix (OCUL) | 0.0 | $153k | 18k | 8.47 |
|
|
| Neogenomics Com New (NEO) | 0.0 | $141k | 19k | 7.42 |
|
|
| Ardelyx (ARDX) | 0.0 | $138k | 23k | 5.99 |
|
|
| Oscar Health Cl A (OSCR) | 0.0 | $126k | -95% | 11k | 11.47 |
|
| Nuvation Bio Com Cl A (NUVB) | 0.0 | $124k | 29k | 4.29 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $91k | 26k | 3.51 |
|
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $88k | 405k | 0.22 |
|
|
| Altimmune Com New (ALT) | 0.0 | $85k | 28k | 3.08 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $74k | 28k | 2.63 |
|
|
| Tvardi Therapeutics (TVRD) | 0.0 | $68k | -50% | 21k | 3.18 |
|
| Geron Corporation (GERN) | 0.0 | $64k | 43k | 1.49 |
|
|
| Blue Gold *w Exp 04/01/203 (BGLWW) | 0.0 | $60k | 300k | 0.20 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.0 | $57k | 78k | 0.73 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $46k | 13k | 3.51 |
|
|
| Evolent Health Cl A (EVH) | 0.0 | $32k | 14k | 2.28 |
|
|
| Canopy Growth Corporation Com New (CGC) | 0.0 | $29k | 30k | 0.95 |
|
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $18k | 375k | 0.05 |
|
|
| Beyond Meat (BYND) | 0.0 | $13k | 19k | 0.70 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2026 Q1 filed May 15, 2026
- Farallon Capital Management 2025 Q4 amended filed May 15, 2026
- Farallon Capital Management 2024 Q4 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q1 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q2 amended filed Feb. 17, 2026
- Farallon Capital Management 2025 Q3 restated filed Feb. 17, 2026
- Farallon Capital Management 2025 Q4 filed Feb. 17, 2026
- Farallon Capital Management 2023 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2023 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q3 filed Nov. 14, 2025